Similar Search Results

Impact of product patents on pharmaceutical market structure and prices in India

Chaudhuri, Sudip - 2018

Persistent link: https://www.econbiz.de/10011963838

Optimal patent policy for pharmaceutical industry

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2020

Persistent link: https://www.econbiz.de/10012439514

Patent Protection, Creative Destruction, and Generic Entry in Pharmaceuticals : Evidence from Patent and Pricing Data

Marco, Alan C. - 2006

This paper merges patent citation data with data on pharmaceutical patent expirations, generic entry, and pricing to explore the effects of observable patent characteristics on off-patent and on-patent pharmaceutical pricing. Using a sample of drug patents facing generic entry in the 1990s, I...

Persistent link: https://www.econbiz.de/10012732596

Product patents and access to innovative medicines in a post-trips-era

Watal, Jayashree; Dai, Rong - 2019 - Manuscript date: 28 March 2019

This WTO working paper studies availability and affordability of new and innovative pharmaceuticals in a post-TRIPS era … the introduction of product patents in pharmaceuticals affect the likelihood of pharmaceutical firms to launch new and … finds that introduction of product patent for pharmaceuticals in the patent law has a positive effect on launch likelihood …

Persistent link: https://www.econbiz.de/10011992779

Neglected dimension of the inventive step as applied to pharmaceutical and biotechnological products : the case of Sri Lanka's patent law

Fernando, Ruwan - 2023

Apart from the basic statutory definition in section 65 of the Intellectual Property Act of Sri Lanka, there do not appear to be any detailed statutory guidelines or judicial decisions to provide any framework for the assessment of inventive step in Sri Lanka. The current statutory definition is...

Persistent link: https://www.econbiz.de/10014324836

Big pharma and monopoly capitalism: a long-term view

Dosi, Giovanni; Marengo, Luigi; Staccioli, Jacopo; … - 2021

Are IPRs institutions meant to foster innovative activities or conversely to secure appropriation and profitability? Taking stock of a long-term empirical evidence on the pharmaceutical sector in the US, we can hardly support IPRs intended as an innovation rewarding institution. According to our...

Persistent link: https://www.econbiz.de/10012604733

The effect of intellectual property rights on domestic innovation in the pharmaceutical sector

Gamba, Simona - 2016

This paper analyses the causal impact of Intellectual Property Rights (IPR) on pharmaceutical innovation in a panel of 74 countries. The identification strategy exploits the different timing across countries of two sets of IPR reforms. Domestic innovation is measured as citation-weighted...

Persistent link: https://www.econbiz.de/10011509446

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...

Persistent link: https://www.econbiz.de/10012802183

Pharmaceutical Patents and Expropriation in Indian Bilateral Investment Treaties

Ranjan, Prabhash - 2017

This chapter discusses whether foreign investors, specifically pharmaceutical companies, could challenge India's regulatory measures that impact their patents under India's BITs. More specifically, the paper will focus on whether regulatory measures such as compulsory licensing of pharmaceutical...

Persistent link: https://www.econbiz.de/10012959457

Patentability of Pharmaceutical Inventions Under TRIPS : Domestic Court Practice as a Test for International Policy Space

Grosse Ruse-Khan, Henning - 2017

This article examines the leeway the TRIPS Agreement grants to WTO Members to define their own standard of patentability in the field of pharmaceutical inventions. To this end, the contribution adopts an anecdotal approach: instead of abstractly analyzing the boundaries set by Article 27 TRIPS,...

Persistent link: https://www.econbiz.de/10012969977

1
2
3
4
5
6
7
8
9
10
Next
Last